Cargando…
Protocol for stage 2 of the GaP study (genetic testing acceptability for Paget's disease of bone): A questionnaire study to investigate whether relatives of people with Paget's disease would accept genetic testing and preventive treatment if they were available
BACKGROUND: Paget's disease of bone (PDB) disrupts normal bone architecture and causes pain, deformity, deafness, osteoarthritis, and fractures. Genetic factors play a role in PDB and genetic tests are now conducted for research purposes. It is thus timely to investigate the potential for a cli...
Autores principales: | Langston, Anne L, Johnston, Marie, Francis, Jill, Robertson, Clare, Campbell, Marion K, Entwistle, Vikki A, Marteau, Theresa, MacLennan, Graeme, Weinman, John, McCallum, Marilyn, Miedzybrodska, Zosia, Charnock, Keith, Ralston, Stuart H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2442429/ https://www.ncbi.nlm.nih.gov/pubmed/18510762 http://dx.doi.org/10.1186/1472-6963-8-116 |
Ejemplares similares
-
Protocol for stage 1 of the GaP study (Genetic testing acceptability for Paget's disease of bone): an interview study about genetic testing and preventive treatment: would relatives of people with Paget's disease want testing and treatment if they were available?
por: Langston, Anne L, et al.
Publicado: (2006) -
Genetic Determinants of Paget’s Disease of Bone
por: Makaram, Navnit S., et al.
Publicado: (2021) -
Zoledronate in the prevention of Paget’s (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1-mediated Paget’s disease of bone
por: Cronin, Owen, et al.
Publicado: (2019) -
Update on the pathogenesis and genetics of Paget’s disease of bone
por: Gennari, Luigi, et al.
Publicado: (2022) -
Antibody Response to Paramyxoviruses in Paget’s Disease of Bone
por: Visconti, Micaela Rios, et al.
Publicado: (2017)